Literature DB >> 15919905

Localization of regions in CD46 that interact with adenovirus.

Anuj Gaggar1, Dmitry M Shayakhmetov, M Kathryn Liszewski, John P Atkinson, André Lieber.   

Abstract

A variety of pathogens use CD46, a ubiquitously expressed membrane protein that regulates complement activation, as a cellular attachment receptor. While the CD46 binding sites of several pathogens, including measles virus, Neisseria gonorrhea, and human herpesvirus 6, have been described, the region of CD46 responsible for adenovirus binding has not been determined. In this study, we used competition experiments with known CD46 ligands, CD46-specific antibodies, and a set of CD46 mutants to localize the binding domain for the group B adenovirus serotype 35 (Ad35). Our results show that Ad35 competes with measles virus for binding to CD46 but not with complement protein C3b. We further show that this interaction is a protein-protein interaction and that N glycosylations do not critically contribute to infection with Ad35 fiber-containing Ad vectors. Our data demonstrate that the native conformation of the CCP2 domain is crucial for Ad35 binding and that the substitution of amino acids at positions 130 to 135 or 152 to 156 completely abolishes the receptor function of CD46. These regions localize to the same planar face of CD46 and likely form an extended adenovirus binding surface, since no single amino acid substitution within these areas eliminates virus binding. Finally, we demonstrate that the infection with a virus possessing human group B serotype Ad11 fibers is also mediated by the CCP2 domain. This information is important to better characterize the mechanisms of the receptor recognition by adenovirus relative to other pathogens that interact with CD46, and it may help in the design of antiviral therapeutics against adenovirus serotypes that use CD46 as a primary cellular attachment receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919905      PMCID: PMC1143628          DOI: 10.1128/JVI.79.12.7503-7513.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change.

Authors:  Jianrong Li; Vanessa R Melanson; Anne M Mirza; Ronald M Iorio
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Authors:  N A Clarkson; R Kaufman; D M Lublin; T Ward; P A Pipkin; P D Minor; D J Evans; J W Almond
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 3.  Control of the complement system.

Authors:  M K Liszewski; T C Farries; D M Lublin; I A Rooney; J P Atkinson
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

4.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

5.  RASMOL: biomolecular graphics for all.

Authors:  R A Sayle; E J Milner-White
Journal:  Trends Biochem Sci       Date:  1995-09       Impact factor: 13.807

6.  The role of the adenovirus protease on virus entry into cells.

Authors:  U F Greber; P Webster; J Weber; A Helenius
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

7.  The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor.

Authors:  A Maisner; J Alvarez; M K Liszewski; D J Atkinson; J P Atkinson; G Herrler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement.

Authors:  M K Liszewski; J P Atkinson
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

9.  Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion.

Authors:  C J Buchholz; U Schneider; P Devaux; D Gerlier; R Cattaneo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).

Authors:  M Manchester; A Valsamakis; R Kaufman; M K Liszewski; J Alvarez; J P Atkinson; D M Lublin; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more
  27 in total

Review 1.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Structural variations in species B adenovirus fibers impact CD46 association.

Authors:  Lars Pache; Sangita Venkataraman; Vijay S Reddy; Glen R Nemerow
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

Review 3.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

Review 4.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

5.  1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.

Authors:  Katherine J D A Excoffon; Jonathan R Bowers; Priyanka Sharma
Journal:  Recent Res Dev Virol       Date:  2014

Review 6.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

7.  A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

Authors:  Sebastian Tuve; Hongjie Wang; Carol Ware; Ying Liu; Anuj Gaggar; Kathrin Bernt; Dmitry Shayakhmetov; Zongyi Li; Robert Strauss; Daniel Stone; André Lieber
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

8.  Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.

Authors:  M Takagi-Kimura; T Yamano; M Tagawa; S Kubo
Journal:  Cancer Gene Ther       Date:  2014-02-28       Impact factor: 5.987

9.  Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob.

Authors:  Hongjie Wang; Yen-Chywan Liaw; Daniel Stone; Oleksandr Kalyuzhniy; Imameddin Amiraslanov; Sebastian Tuve; Christophe L M J Verlinde; Dmitry Shayakhmetov; Thilo Stehle; Steve Roffler; André Lieber
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

10.  Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.

Authors:  Misato Takagi-Kimura; Tomoki Yamano; Atsuko Tamamoto; Nobutaka Okamura; Haruki Okamura; Tomoko Hashimoto-Tamaoki; Masatoshi Tagawa; Noriyuki Kasahara; Shuji Kubo
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.